APA-viite (7. p.)

Gloyn, A., Diatloff-Zito, C., Edghill, E., Bellanné-Chantelot, C., Nivot, S., Coutant, R., . . . Robert, J. (2006). KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.

Chicago-viite (17. p.)

Gloyn, A., C. Diatloff-Zito, E. Edghill, C. Bellanné-Chantelot, S. Nivot, R. Coutant, S. Ellard, A. Hattersley, ja J. Robert. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.

MLA-viite (9. p.)

Gloyn, A., et al. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.